CLINAM Award 2022 for special achievements in nanomedicine for Stéfan Halbherr and InnoMedica
The Scientific Committee of the European Foundation for Clinical Nanomedicine (CLINAM) honors Stéfan Halbherr, Country Manager InnoMedica Switzerland AG, with the prestigious Dwarf Award. This prize is awarded annually to successful researchers in the field of nanomedicine. In previous years, for instance, Chezy Barenholz, one of the inventors of the first nanomedical cancer drug, or Omid Farokhzad, the head of the world-renowned Farokhzad Lab at Harvard University, were honored with the award.
The award was handed over by Beat Löffler, MD, founder and CEO of CLINAM, on Monday, March 28, 2022 at InnoMedica's manufacturing facility in Marly.